Chapter 282: Intermediate Genetic Enhancer
Just as Huanyu Biotech is thriving, Longkang Pharmaceutical of Xujia, Lucheng, Jiangzhou, is also developing rapidly.
Although an aphrodisiac is a thing that cannot be put on the table, its ability to make money is coveted by any pharmaceutical company, and Aili God is precisely a "miracle drug" that can make men crazy.
Sales continue to climb to new heights.
In 2019, the single-day sales reached the 2 million mark, which made people in the industry envious and jealous.
Originally, I thought that this was already a remarkable number, but after the beginning of 2020, sales not only did not have a weak period, but also continued to set new records.
2020 Chinese New Year's Eve daily sales of 3 million!
February 14 Valentine's Day sales of 4 million!
38 Women's Day sales of 5 million!
On the night before May 1, sales reached a staggering 7 million.
Such a sales amount made the senior management of Longkang Pharmaceutical smile.
Facts have proved that men don't like to use aphrodisiacs, but many drugs are not willing to buy them over time under the banner of aphrodisiac.
And Ailishen does not advertise, purely relying on the power of the masses by word of mouth, and in less than a year, it has climbed to the first place of domestic aphrodisiacs.
If calculated according to the daily sales of 7 million, the annual sales will reach a terrifying 2.55 billion RMB, equivalent to 365 million US dollars.
According to Pfizer's 2019 financial report, Viagra's global sales in 2019 were only $1.5 billion, while Aleris has reached 24% of it just by relying on the Chinese market.
Once the goods are distributed around the world, more than Viagra is just around the corner.
At this time, in the office of the chairman of Kyoto Longkang Pharmaceutical, Xu Yuting looked at yesterday's Ailishen sales statistics table, and her face couldn't help but show joy.
A company's products are the first in the industry, which represents not only money, but also a recognition of the market and an honor.
Of course, market recognition also represents money......
Xu Yuting glanced at Ailishen and looked at the company's other product sales reports, and soon the smile on the corner of her mouth disappeared.
Although the market environment is not good in 2020, and the financial crisis caused by the United States has swept the world, resulting in a decline in the economies of various countries, the medical industry has risen against the trend, with the performance of major pharmaceutical companies doubling and their stock prices hitting new highs.
Longkang Pharmaceutical is no exception, and the sales of its products have increased greatly compared with last year.
However, the shortcomings of Longkang Pharmaceutical are also obvious, the innovation is insufficient, and the first and second classes of new drugs sold are all generic drugs from abroad, while the self-developed drugs are mostly four, five or six drugs, and even the third class is very few.
Although I know that scientific research is not achieved overnight, it is still frustrating.
Compared with a string of foreign agent drugs, Elishen, who is hanging high in the sales table TOP1 at this time, stands out from the crowd.
Xu Yuting put down the sales report and asked, "What has been the recent movement of Huanyu Biotech?"
"I was about to tell you that they are developing a new drug for viral hepatitis B and are said to have completed the screening of active compounds," said the executive director. ”
Xu Yuting was surprised: "What, it's really fake?"
He Junfeng, deputy director of the Institute of Hepatitis B of the Chinese Academy of Sciences, has been hired to join Huanyu Biotech, but the specific position is not announced on the website. ”
"Hepatitis B ......"
Xu Yuting's left index finger kept tapping on the tabletop, frowning and groaning.
Universal Biotech is really a fierce horse, and it is great for general pharmaceutical companies to have a clinical trial of a class of new drugs in a year, but they have already entered the clinical trial stage of two class I new drugs.
The medical community is encouraged by the fact that the HIV drug that has attracted much attention has successfully passed the first phase of clinical trials and entered the second phase of clinical trials.
The second is an anti-allergy agent that has just entered clinical trials, which is said to be effective in treating cough caused by allergies, and also has a very good effect on hay fever.
It's only been a few days, and I've started to study hepatitis B again, and this kind of research and development ability is simply terrible.
If this is true, with these three new drugs alone, Huanyu Biotech will definitely become a real dark horse in the international pharmaceutical industry!
No!
As long as the HIV drug successfully passes the phase III clinical trial, it is enough for Oneworld Biotech to stand at the top of the world's pharmaceutical industry!
Just as Xu Yuting was groaning, the executive director said: "In addition, I just heard that Huanyu Biotech is preparing for a pharmaceutical alliance and has submitted an application to the Ministry of Civil Affairs. ”
"Oh, is it?" Xu Yuting was surprised again.
"Yes, I guess Cosmos is hoping to ...... it."
Xu Yuting didn't hear what the executive director said, she thought of her niece Xu Shuangyu, who was still studying in London, England, and now it seems that her decision was a little unwise......
......
With the sudden rise of Huanyu Biotech, the domestic pharmaceutical industry is surging and unpredictable, and capital, rights, conspiracies, and tricks are constantly staged.
As the actual controller of Huanyu Biotech, Zhou Wen is completely hidden behind the scenes.
Looking at domestic and foreign companies, there are not many bosses like him who are completely decentralized.
From a business point of view, this has great drawbacks, such as a serious lack of control over the company, and it is easy to put Zhou Wen, the boss, in the air.
However, this is only in general, and it is aimed at companies in general.
Uniworld does not have this problem, because first of all, all the technologies and patents are owned by Huanyu Laboratory, and the laboratory is fully controlled by Zhou Wen.
Secondly, all the scientific researchers in the laboratory were recruited and trained by him, and he firmly tied them with shares, so he didn't have to worry about them leaving.
Even if everyone betrayed him and the company didn't go out of business, he didn't care at all, and gave 1 million to the betrayer...... As long as there is a system, everything is not just a joke!
Applause in understanding.
Universal Labs.
Zhou Wen is also making intermediate gene enhancers.
After three days and two nights of sleeplessness, it was time for the final step.
As long as you add a raw material purchased from the system ETSD1031 to the solvent and ensure that the solvent does not evaporate, it is considered successful.
This is the first time he has done this, and he doesn't know if he will succeed.
Take two deep breaths ETSD1031 extracting from the container with a gun and pour the ETSD1031 into the round-bottom flask.
As soon as ETSD1031 came into contact with the light blue solvent, it immediately sank directly to the bottom of the solvent like a ball of black ink.
It then diffuses from the bottom of the solvent in all directions, like smoke, forming a black cloud of smoke.
When the pale blue solvent was rendered dark blue by the black smoke cloud, it gradually began to boil.
A large amount of white water vapor evaporates upwards from the bottom of the round-bottom flask and then flows into the tube through a catheter at the mouth of the flask.
The boiling lasted for about a minute, and when it calmed down, the liquid in the flask turned a rose-red color.
At this moment, a system prompt sounded in Zhou Wen's ears.
You have successfully crafted an Intermediate Gene Enhancer with +5300 XP. Obtained biologics 1082, indications: urticaria×3]
Congratulations on becoming a senior pharmacist and obtaining a ×1...... of bio-neurorestorative formulations]